Stocks and Investing
Stocks and Investing
Mon, July 22, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Edward Nash Maintained (VRNA) at Strong Buy with Increased Target to $37 on, Jul 22nd, 2024
Edward Nash of Canaccord Genuity, Maintained "Verona Pharma plc" (VRNA) at Strong Buy with Increased Target from $35 to $37 on, Jul 22nd, 2024.
Edward has made no other calls on VRNA in the last 4 months.
There are 3 other peers that have a rating on VRNA. Out of the 3 peers that are also analyzing VRNA, 0 agree with Edward's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Edward
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $36 on, Monday, July 1st, 2024
- Joon Lee of "Truist Securities" Maintained at Strong Buy with Increased Target to $38 on, Friday, June 28th, 2024
- Yasmeen Rahimi of "Piper Sandler" Maintained at Buy with Increased Target to $36 on, Tuesday, April 16th, 2024
Contributing Sources